[EN] 01.02.2020 – PhytoXtract SA will be focusing on Medical Cannabis and therefore selling part of its company and brand porfolio
Plan-les-Ouates, 01.02.2020 – PhytoXtract SA is selling one of its brand “Cannaliz” and subsidiairy PhytoCloud SA in order to fully focus on both GMP (Good Manufacturing Practices) and GDP (Good Distribution Practices). A quality management system will be implemented to obtain the necessary authorisation to offer a wide range of formulations; pure CBD/THC, broad/full spectrum to customized orders.
However, PhytoXtract SA, through cannaxtract labs, remains a sub-contracting provider for other cannabis cbd/thc companies in the production of a wide range of products.
- Contact for pharmacies : email@example.com
- Contact for sub-contracting third-party production : firstname.lastname@example.org
- Media Contact : email@example.com
PhytoXtract SA, ch des Aulx 14, 1228 Plan-les-Ouates